Search Results - "Sole, Amparo"
-
1
-
2
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study
Published in The Journal of heart and lung transplantation (01-10-2018)“…Invasive aspergillosis (IA) is a frequent complication in lung transplant recipients (LTRs). Clinical risk factors for IA have not been fully characterized,…”
Get full text
Journal Article -
3
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study
Published in Respirology (Carlton, Vic.) (01-12-2022)“…Background and objective Antifibrotic drugs are the standard treatments for patients with idiopathic pulmonary fibrosis (IPF). This study aims to assess the…”
Get full text
Journal Article -
4
Urgent Cadaver Lobar Lung Transplantation in Pediatric Cystic Fibrosis: Report of a Case
Published in Chest (01-03-2014)Get full text
Journal Article -
5
Multiresistant organisms: bacteria and beyond
Published in Current opinion in organ transplantation (01-06-2022)“…Infections with multiresistant organisms are an emerging problem, cause early mortality post lung transplantation and are sometimes associated with graft…”
Get full text
Journal Article -
6
Multiresistant organisms: bacteria and beyond
Published in Current opinion in organ transplantation (11-03-2022)Get full text
Journal Article -
7
Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries
Published in Thorax (01-12-2014)“…Individuals with chronic diseases and parent caregivers are at increased risk for symptoms of depression and anxiety. Prevalence of psychological symptoms was…”
Get more information
Journal Article -
8
Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B
Published in International journal of antimicrobial agents (01-11-2008)“…Abstract Immunocompromised patients, especially solid organ transplant (SOT) and hematopoietic stem cell transplant recipients, have a high morbidity and…”
Get full text
Journal Article Conference Proceeding -
9
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
Published in Leukemia & lymphoma (02-01-2019)“…Post-transplant lymphoproliferative disorders (PTLD) are a rare complication after both solid organ (SOT) and allogeneic hematopoietic stem cell…”
Get full text
Journal Article -
10
Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection
Published in Journal of cystic fibrosis (01-11-2021)“…•Patients with CF and P. aeruginosa previously received 6-month cyclic ALIS or TIS.•Here, patients received cyclic ALIS for 2 years with no cumulative…”
Get full text
Journal Article -
11
Fungal infections after lung transplantation
Published in Current opinion in pulmonary medicine (01-05-2009)“…Lung transplant's Achilles heel is chronic rejection. This is the reason why high immunosuppression is used, which leads to the development of infections…”
Get full text
Journal Article -
12
Scedosporium apiospermum disseminated infection in a single lung transplant recipient
Published in Revista iberoamericana de micologia (01-07-2011)“…Scedosporium spp. are filamentous fungi, and the 2 most important species are Scedosporium prolificans and Scedosporium apiospermum. S. apiospermum accounts…”
Get more information
Journal Article -
13
Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients
Published in Transplant infectious disease (01-12-2016)“…Appropriate post‐transplant immunosuppressive regimens that avoid acute rejection, while reducing risk of viral reactivation, have been sought, but remain a…”
Get full text
Journal Article -
14
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis
Published in EBioMedicine (01-02-2015)“…The best investigational drug to treat cystic fibrosis (CF) patients with the most common CF-causing mutation (F508del) is VX-809 (lumacaftor) which recently…”
Get full text
Journal Article -
15
Evolving Indications for Heart-Lung Transplant in Spain
Published in Transplantation proceedings (01-11-2022)“…•Over the last decades the indications for heart-lung transplant have been changing.•In the recent period the indications are mainly congenital heart…”
Get full text
Journal Article -
16
Mold infections in lung transplants
Published in Revista iberoamericana de micologia (01-10-2014)“…Invasive infections by molds, mainly Aspergillus infections, account for more than 10% of infectious complications in lung transplant recipients. These…”
Get more information
Journal Article -
17
Development and electronic validation of the revised Cystic Fibrosis Questionnaire (CFQ-R Teen/Adult): New tool for monitoring psychosocial health in CF
Published in Journal of cystic fibrosis (01-09-2018)“…The Cystic Fibrosis Questionnaire-Revised (CFQ-R+14) is a disease-specific, health-related quality of life instrument for cystic fibrosis (CF) patients…”
Get full text
Journal Article -
18
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection
Published in American journal of transplantation (01-02-2018)“…Scedosporium is an important pathogen in cystic fibrosis (CF) and post‐transplantation, but it rarely causes invasive infection. Treatment remains challenging,…”
Get full text
Journal Article -
19
Filamentous fungi in the airway of patients with cystic fibrosis: Just spectators?
Published in Revista iberoamericana de micologia (01-10-2021)“…There are important advances in the management of bacterial infection in patients with cystic fibrosis (CF), but there are many gaps in the field of fungal…”
Get full text
Journal Article -
20
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
Published in The Journal of heart and lung transplantation (01-03-2013)“…Background Prophylaxis with inhaled liposomal amphotericin B has proven to be safe and effective for preventing infection due to Aspergillus spp in lung…”
Get full text
Journal Article